An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs)

References

• Rogozinska E, Marlin N, Jackson L, et al. Effects of antenatal diet and physical activity on maternal and fetal outcomes: individual patient data meta-analysis and health economic evaluation. Health Technol Assess. 2017 Aug;21(41):1–158. PubMed PMID: 28795682; PubMed Central PMCID: PMCPMC5572115.
   Google Scholar
• McGowan CA, McAuliffe FM. The influence of maternal glycaemia and dietary glycaemic index on pregnancy outcome in healthy mothers. Br J Nutr. 2010 Jul;104(2):153–159. PubMed PMID: 20307352.
   Google Scholar
• Group HSCR, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008 May 8;358(19):1991–2002. PubMed PMID: 18463375.
   Google Scholar
• Safi J, Joyeux L, Chalouhi GE. Periconceptional folate deficiency and implications in neural tube defects. J Pregnancy. 2012;2012:295083. PubMed PMID: 22900183; PubMed Central PMCID: PMCPMC3415073.
   Google Scholar
• Werner EF, Froehlich RJ. The potential role for myoinositol in the prevention of gestational diabetes mellitus. Am J Perinatol. 2016 Nov;33(13):1236–1241. PubMed PMID: 27213831.
   Google Scholar
• Noventa M, Vitagliano A, Quaranta M, et al. Preventive and therapeutic role of dietary inositol supplementation in periconceptional period and during pregnancy: a summary of evidences and future applications. Reprod Sci. 2016 Mar;23(3):278–288. PubMed PMID: 26175275.
   Google Scholar
• Pak Y, Huang LC, Lilley KJ, et al. In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues. J Biol Chem. 1992 Aug 25;267(24):16904–16910. PubMed PMID: 1387397.
   Google Scholar
• Beemster P, Groenen P, Steegers-Theunissen R. Involvement of inositol in reproduction. Nutr Rev. 2002 Mar;60(3):80–87. PubMed PMID: 11908744.
   Google Scholar
• Wong YH, Kalmbach SJ, Hartman BK, et al. Immunohistochemical staining and enzyme activity measurements show myo-inositol-1-phosphate synthase to be localized in the vasculature of brain. J Neurochem. 1987 May;48(5):1434–1442. PubMed PMID: 2435847.
   Google Scholar
• Loewus MW, Loewus FA, Brillinger GU, et al. Stereochemistry of the myo-inositol-1-phosphate synthase reaction. J Biol Chem. 1980 Dec 25;255(24):11710–11712. PubMed PMID: 7002927.
   Google Scholar
• Michell RH. Inositol derivatives: evolution and functions. Nat Rev Mol Cell Biol. 2008 Feb;9(2):151–161. PubMed PMID: 18216771.
   Google Scholar
• Monastra G, Unfer V, Harrath AH, et al. Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients. Gynecol Endocrinol. 2017 Jan;33(1):1–9. PubMed PMID: 27898267.
   Google Scholar
• Schneider S. Inositol transport proteins. FEBS Lett. 2015 Apr 28;589(10):1049–1058. PubMed PMID: 25819438.
   Google Scholar
• Aouameur R, Da Cal S, Bissonnette P, et al. SMIT2 mediates all myo-inositol uptake in apical membranes of rat small intestine. Am J Physiol Gastrointest Liver Physiol. 2007 Dec;293(6):G1300–G1307. PubMed PMID: 17932225.
   Google Scholar
• Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature. 2006 Oct 12;443(7112):651–657. PubMed PMID: 17035995.
   Google Scholar
• Bizzarri M, Fuso A, Dinicola S, et al. Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert Opin Drug Metab Toxicol. 2016 Oct;12(10):1181–1196. PubMed PMID: 27351907.
   Google Scholar
• Lagana AS, Garzon S, Casarin J, et al. Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach. Trends Endocrinol Metab. 2018 Nov;29(11):768–780. PubMed PMID: 30270194.
   Google Scholar
• Nestler JE, Unfer V. Reflections on inositol(s) for PCOS therapy: steps toward success. Gynecol Endocrinol. 2015 Jul;31(7):501–505. PubMed PMID: 26177098.
   Google Scholar
• Facchinetti F, Appetecchia M, Aragona C, et al. Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond. Expert Opin Drug Metab Toxicol. 2020 Mar;16(3):255–274. PubMed PMID: 32129111.
   Google Scholar
• Unfer V, Nestler JE, Kamenov ZA, et al. Effects of Inositol(s) in women with PCOS: a systematic review of randomized controlled trials. Int J Endocrinol. 2016;2016:1849162. PubMed PMID: 27843451; PubMed Central PMCID: PMCPMC5097808.
   Google Scholar
• Croze ML, Soulage CO. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 2013 Oct;95(10):1811–1827. PubMed PMID: 23764390.
   Google Scholar
• Sun TH, Heimark DB, Nguygen T, et al. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. Biochem Biophys Res Commun. 2002 May 10;293(3):1092–1098. PubMed PMID: 12051772.
   Google Scholar
• Heimark D, McAllister J, Larner J. Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls. Endocr J. 2014;61(2):111–117. PubMed PMID: 24189751.
   Google Scholar
• Chukwuma CI, Ibrahim MA, Islam MS. Myo-inositol inhibits intestinal glucose absorption and promotes muscle glucose uptake: a dual approach study. J Physiol Biochem. 2016 Dec;72(4):791–801. PubMed PMID: 27601253.
   Google Scholar
• Milewska EM, Czyzyk A, Meczekalski B, et al. Inositol and human reproduction. From cellular metabolism to clinical use. Gynecol Endocrinol. 2016 Sep;32(9):690–695. PubMed PMID: 27595157.
   Google Scholar
• Monastra G, Sambuy Y, Ferruzza S, et al. Alpha-lactalbumin effect on myo-inositol intestinal absorption: in vivo and in vitro. Curr Drug Deliv. 2018;15(9):1305–1311. PubMed PMID: 29745333.
   Google Scholar
• Permyakov EA, Berliner LJ. Alpha-lactalbumin: structure and function. FEBS Lett. 2000 May 19;473(3):269–274. PubMed PMID: 10818224.
   Google Scholar
• Montanino Oliva M, Buonomo G, Calcagno M, et al. Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women. J Ovarian Res. 2018 May 10;11(1):38. PubMed PMID: 29747700; PubMed Central PMCID: PMCPMC5944130.
   Google Scholar
• Carlomagno G, Unfer V. Inositol safety: clinical evidences. Eur Rev Med Pharmacol Sci. 2011 Aug;15(8):931–936. PubMed PMID: 21845803.
   Google Scholar
• Vitagliano A, Saccone G, Cosmi E, et al. Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials. Arch Gynecol Obstet. 2019 Jan;299(1):55–68. PubMed PMID: 30564926.
   Google Scholar
• Crawford TJ, Crowther CA, Alsweiler J, et al. Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes. Cochrane Database Syst Rev. 2015 Dec 17;12:CD011507. PubMed PMID: 26678256; PubMed Central PMCID: PMCPMC6599829.
   Google Scholar
• Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diab Rep. 2016 Jan;16(1):7. PubMed PMID: 26742932; PubMed Central PMCID: PMCPMC6675405.
   Google Scholar
• Chiefari E, Arcidiacono B, Foti D, et al. Gestational diabetes mellitus: an updated overview. J Endocrinol Invest. 2017 Sep;40(9):899–909. PubMed PMID: 28283913.
   Google Scholar
• Immanuel J, Simmons D. Screening and treatment for early-onset gestational diabetes mellitus: a systematic review and meta-analysis. Curr Diab Rep. 2017 Oct 2;17(11):115. PubMed PMID: 28971305.
   Google Scholar
• Baz B, Riveline JP, Gautier JF. ENDOCRINOLOGY OF PREGNANCY: gestational diabetes mellitus: definition, aetiological and clinical aspects. Eur J Endocrinol. 2016 Feb;174(2):R43–R51. PubMed PMID: 26431552.
   Google Scholar
• International Association Of D, Pregnancy Study Groups Consensus P, Metzger BE, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010 Mar;33(3):676–682. PubMed PMID: 20190296; PubMed Central PMCID: PMCPMC2827530.
   Google Scholar
• Khalifeh A, Eckler R, Felder L, et al. One-step versus two-step diagnostic testing for gestational diabetes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2020 Feb;33(4):612–617. PubMed PMID: 29985079.
   Google Scholar
• Agarwal MM. Gestational diabetes mellitus: an update on the current international diagnostic criteria. World J Diabetes. 2015 Jun 25;6(6):782–791. PubMed PMID: 26131321; PubMed Central PMCID: PMCPMC4478575.
   Google Scholar
• Smirnakis KV, Plati A, Wolf M, et al. Predicting gestational diabetes: choosing the optimal early serum marker. Am J Obstet Gynecol. 2007 Apr;196(4):410e1–6; discussion 410 e6–7. PubMed PMID: 17403439.
   Google Scholar
• Nanda S, Savvidou M, Syngelaki A, et al. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn. 2011 Feb;31(2):135–141. PubMed PMID: 21268030.
   Google Scholar
• Rasanen JP, Snyder CK, Rao PV, et al. Glycosylated fibronectin as a first-trimester biomarker for prediction of gestational diabetes. Obstet Gynecol. 2013 Sep;122(3):586–594. PubMed PMID: 23921871.
   Google Scholar
• Sahu PP, Dubey N, Paroha RD, et al. An emerging tool for diagnosis of a disease and drug development. Asian J Res Pharm Sci. 2011;1:9–16.
   Google Scholar
• Wu L, Cui L, Tam WH, et al. Genetic variants associated with gestational diabetes mellitus: a meta-analysis and subgroup analysis. Sci Rep. 2016 Jul 29;6:30539. PubMed PMID: 27468700; PubMed Central PMCID: PMCPMC4965817.
   Google Scholar
• Dias S, Pheiffer C, Abrahams Y, et al. Molecular biomarkers for gestational diabetes mellitus. Int J Mol Sci. 2018 Sep 26;19(10):2926. PubMed PMID: 30261627; PubMed Central PMCID: PMCPMC6213110.
   Google Scholar
• Houde AA, Guay SP, Desgagne V, et al. Adaptations of placental and cord blood ABCA1 DNA methylation profile to maternal metabolic status. Epigenetics. 2013 Dec;8(12):1289–1302. PubMed PMID: 24113149; PubMed Central PMCID: PMCPMC3933490.
   Google Scholar
• Haertle L, El Hajj N, Dittrich M, et al. Epigenetic signatures of gestational diabetes mellitus on cord blood methylation. Clin Epigenetics. 2017;9:28. PubMed PMID: 28360945; PubMed Central PMCID: PMCPMC5368916.
   Google Scholar
• Wang K, Yuan Y, Cho JH, et al. Comparing the MicroRNA spectrum between serum and plasma. PLoS One. 2012;7(7):e41561. PubMed PMID: 22859996; PubMed Central PMCID: PMCPMC3409228.
   Google Scholar
• Group HSCR. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes. 2009 Feb;58(2):453–459. PubMed PMID: 19011170; PubMed Central PMCID: PMCPMC2628620.
   Google Scholar
• Shah BR, Sharifi F. Perinatal outcomes for untreated women with gestational diabetes by IADPSG criteria: a population-based study. BJOG. 2020 Jan;127(1):116–122. PubMed PMID: 31553136.
   Google Scholar
• Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009 May 23;373(9677):1773–1779. PubMed PMID: 19465232.
   Google Scholar
• Schwartz N, Nachum Z, Green MS. The prevalence of gestational diabetes mellitus recurrence–effect of ethnicity and parity: a metaanalysis. Am J Obstet Gynecol. 2015 Sep;213(3):310–317. PubMed PMID: 25757637.
   Google Scholar
• Herring SJ, Oken E. Obesity and diabetes in mothers and their children: can we stop the intergenerational cycle? Curr Diab Rep. 2011 Feb;11(1):20–27. PubMed PMID: 20963519; PubMed Central PMCID: PMCPMC3191112.
   Google Scholar
• Battista MC, Hivert MF, Duval K, et al. Intergenerational cycle of obesity and diabetes: how can we reduce the burdens of these conditions on the health of future generations? Exp Diabetes Res. 2011;2011:596060. PubMed PMID: 22110473; PubMed Central PMCID: PMCPMC3205776.
   Google Scholar
• Lowe WL Jr., Scholtens DM, Kuang A, et al. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care. 2019 Mar;42(3):372–380. PubMed PMID: 30655380; PubMed Central PMCID: PMCPMC6385693.
   Google Scholar
• International Weight Management in Pregnancy Collaborative G. Effect of diet and physical activity based interventions in pregnancy on gestational weight gain and pregnancy outcomes: meta-analysis of individual participant data from randomised trials. BMJ. 2017 Jul 19;358:j3119. PubMed PMID: 28724518; PubMed Central PMCID: PMCPMC6887834 at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work. HH reports grants from the German Ministry of Education and Research, the Bavarian Ministry of Agriculture and Nutrition, the Bavarian Ministry of Health, the Helmholtz Center Munich, the Else Kroner-Fresenius Foundation, AOK Bavaria, Amway, and the German Research Foundation outside the submitted work. BWJM reports funding from ObsEva during the conduct of the study.
   Google Scholar
• Bruno R, Petrella E, Bertarini V, et al. Adherence to a lifestyle programme in overweight/obese pregnant women and effect on gestational diabetes mellitus: a randomized controlled trial. Matern Child Nutr. 2017 Jul;13(3). PubMed PMID: 27647837; PubMed Central PMCID: PMCPMC6866030. DOI:10.1111/mcn.12333.
   Google Scholar
• Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005 Jun 16;352(24):2477–2486. PubMed PMID: 15951574.
   Google Scholar
• Simeonova-Krstevska S, Bogoev M, Bogoeva K, et al. Maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus treated with diet, metformin or insulin. Open Access Maced J Med Sci. 2018 May 20;6(5):803–807. PubMed PMID: 29875849; PubMed Central PMCID: PMCPMC5985864.
   Google Scholar
• Begum MR, Khanam NN, Quadir E, et al. Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome. J Obstet Gynaecol Res. 2009 Apr;35(2):282–286. PubMed PMID: 19708174.
   Google Scholar
• Glueck CJ, Goldenberg N, Wang P, et al. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod. 2004 Mar;19(3):510–521. PubMed PMID: 14998944.
   Google Scholar
• Glueck CJ, Pranikoff J, Aregawi D, et al. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertil Steril. 2008 Mar;89(3):625–634. PubMed PMID: 17678910.
   Google Scholar
• Vanky E, Stridsklev S, Heimstad R, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab. 2010 Dec;95(12):E448–E455. PubMed PMID: 20926533.
   Google Scholar
• Syngelaki A, Nicolaides KH, Balani J, et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016 Feb 4;374(5):434–443. PubMed PMID: 26840133.
   Google Scholar
• Chiswick C, Reynolds RM, Denison F, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015 Oct;3(10):778–786. PubMed PMID: 26165398; PubMed Central PMCID: PMCPMC4673088.
   Google Scholar
• Celentano C, Matarrelli B, Pavone G, et al. The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial. J Matern Fetal Neonatal Med. 2020 Mar;33(5):743–751. PubMed PMID: 30558466.
   Google Scholar
• Garzon S, Lagana AS, Monastra G. Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors. Expert Opin Drug Metab Toxicol. 2019 Aug 8:1–7 PubMed PMID: 31382802. DOI:10.1080/17425255.2019.1651839.
   Google Scholar
• Matarrelli B, Vitacolonna E, D’Angelo M, et al. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2013 Jul;26(10):967–972. PubMed PMID: 23327487.
   Google Scholar
• D’Anna R, Scilipoti A, Giordano D, et al. myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study. Diabetes Care. 2013 Apr;36(4):854–857. PubMed PMID: 23340885; PubMed Central PMCID: PMCPMC3609506.
   Google Scholar
• Malvasi A, Casciaro F, Minervini MM, et al. Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation. Eur Rev Med Pharmacol Sci. 2014;18(2):270–274. PubMed PMID: 24488919.
   Google Scholar
• D’Anna R, Di Benedetto A, Scilipoti A, et al. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial. Obstet Gynecol. 2015 Aug;126(2):310–315. PubMed PMID: 26241420.
   Google Scholar
• Santamaria A, Di Benedetto A, Petrella E, et al. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. J Matern Fetal Neonatal Med. 2016 Oct;29(19):3234–3237. PubMed PMID: 26698911.
   Google Scholar
• Lubin V, Shojai R, Darmon P, et al. A pilot study of gestational diabetes mellitus not controlled by diet alone: first-line medical treatment with myoinositol may limit the need for insulin. Diabetes Metab. 2016 Jun;42(3):192–195. PubMed PMID: 26948394.
   Google Scholar
• Farren M, Daly N, McKeating A, et al. The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized controlled trial. Diabetes Care. 2017 Jun;40(6):759–763. PubMed PMID: 28325784.
   Google Scholar
• Fraticelli F, Celentano C, Zecca IA, et al. Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial. Acta Diabetol. 2018 Aug;55(8):805–812. PubMed PMID: 29774465.
   Google Scholar
• Pintaudi B, Di Vieste G, Corrado F, et al. Effects of myo-inositol on glucose variability in women with gestational diabetes. Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6567–6572. PubMed PMID: 30338829.
   Google Scholar
• Santamaria A, Alibrandi A, Di Benedetto A, et al. Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs. Am J Obstet Gynecol. 2018 Sep;219(3):300e1–300e6. PubMed PMID: 29859136.
   Google Scholar
• Facchinetti F, Vijai V, Petrella E, et al. Food glycemic index changes in overweight/obese pregnant women enrolled in a lifestyle program: a randomized controlled trial. AJOG MFM. 2019;1(3):100030.
   Google Scholar
• D’Anna R, Di Benedetto V, Rizzo P, et al. Myo-inositol may prevent gestational diabetes in PCOS women. Gynecol Endocrinol. 2012 Jun;28(6):440–442. PubMed PMID: 22122627.
   Google Scholar
• Ferrari F, Facchinetti F, Ontiveros AE, et al. The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity. Am J Obstet Gynecol. 2016 Oct;215(4):503e1–8. PubMed PMID: 27255472.
   Google Scholar
• Longo M, Alrais M, Tamayo EH, et al. Vascular and metabolic profiles in offspring born to pregnant mice with metabolic syndrome treated with inositols. Am J Obstet Gynecol. 2019 Mar;220(3):279e1–279e9. PubMed PMID: 30521799.
   Google Scholar
• Copp AJ, Stanier P, Greene ND. Neural tube defects: recent advances, unsolved questions, and controversies. Lancet Neurol. 2013 Aug;12(8):799–810. PubMed PMID: 23790957; PubMed Central PMCID: PMCPMC4023229.
   Google Scholar
• Kirke PN, Molloy AM, Daly LE, et al. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993 Nov;86(11):703–708. PubMed PMID: 8265769.
   Google Scholar
• MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the medical research council vitamin study. Lancet. 1991 Jul 20;338(8760):131–137. PubMed PMID: 1677062.
   Google Scholar
• Oakley GP Jr., Bell KN, Weber MB. Recommendations for accelerating global action to prevent folic acid-preventable birth defects and other folate-deficiency diseases: meeting of experts on preventing folic acid-preventable neural tube defects. Birth Defects Res A Clin Mol Teratol. 2004 Nov;70(11):835–837. PubMed PMID: 15390317.
   Google Scholar
• Kancherla V, Wagh K, Johnson Q, et al. A 2017 global update on folic acid-preventable spina bifida and anencephaly. Birth Defects Res. 2018 Aug 15;110(14):1139–1147. PubMed PMID: 30070772.
   Google Scholar
• Rasmussen SA, Chu SY, Kim SY, et al. Maternal obesity and risk of neural tube defects: a metaanalysis. Am J Obstet Gynecol. 2008 Jun;198(6):611–619. PubMed PMID: 18538144.
   Google Scholar
• Kucera J. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med. 1971 Aug;7(2):73–82. PubMed PMID: 5095696.
   Google Scholar
• Eriksson UJ, Naeser P, Brolin SE. Increased accumulation of sorbitol in offspring of manifest diabetic rats. Diabetes. 1986 Dec;35(12):1356–1363. PubMed PMID: 3770312.
   Google Scholar
• Eriksson UJ, Brolin SE, Naeser P. Influence of sorbitol accumulation on growth and development of embryos cultured in elevated levels of glucose and fructose. Diabetes Res. 1989 May;11(1):27–32. PubMed PMID: 2515932.
   Google Scholar
• Hod M, Star S, Passonneau JV, et al. Effect of hyperglycemia on sorbitol and myo-inositol content of cultured rat conceptus: failure of aldose reductase inhibitors to modify myo-inositol depletion and dysmorphogenesis. Biochem Biophys Res Commun. 1986 Nov 14;140(3):974–980. PubMed PMID: 3096334.
   Google Scholar
• Hod M, Star S, Passonneau J, et al. Glucose-induced dysmorphogenesis in the cultured rat conceptus: prevention by supplementation with myo-inositol. Isr J Med Sci. 1990 Oct;26(10):541–544. PubMed PMID: 2249926.
   Google Scholar
• Zabihi S, Loeken MR. Understanding diabetic teratogenesis: where are we now and where are we going? Birth Defects Res A Clin Mol Teratol. 2010 Oct;88(10):779–790. PubMed PMID: 20706996; PubMed Central PMCID: PMCPMC5070114.
   Google Scholar
• Cockroft DL, Coppola PT. Teratogenic effects of excess glucose on head-fold rat embryos in culture. Teratology. 1977 Oct;16(2):141–146. PubMed PMID: 412267.
   Google Scholar
• Hunter ES 3rd, Sadler TW. D-(-)-beta-hydroxybutyrate-induced effects on mouse embryos in vitro. Teratology. 1987 Oct;36(2):259–264. PubMed PMID: 3424210.
   Google Scholar
• Reece EA, Wu YK. Prevention of diabetic embryopathy in offspring of diabetic rats with use of a cocktail of deficient substrates and an antioxidant. Am J Obstet Gynecol. 1997 Apr;176(4):790–7;discussion 797–8. PubMed PMID: 9125602.
   Google Scholar
• Zhong J, Xu C, Gabbay-Benziv R, et al. Superoxide dismutase 2 overexpression alleviates maternal diabetes-induced neural tube defects, restores mitochondrial function and suppresses cellular stress in diabetic embryopathy. Free Radic Biol Med. 2016 Jul;96:234–244. PubMed PMID: 27130031; PubMed Central PMCID: PMCPMC4912469.
   Google Scholar
• Greene ND, Massa V, Copp AJ. Understanding the causes and prevention of neural tube defects: insights from the splotch mouse model. Birth Defects Res A Clin Mol Teratol. 2009 Apr;85(4):322–330. PubMed PMID: 19180568.
   Google Scholar
• Fine EL, Horal M, Chang TI, et al. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes. 1999 Dec;48(12):2454–2462. PubMed PMID: 10580436.
   Google Scholar
• Hendricks KA, Nuno OM, Suarez L, et al. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology. 2001 Nov;12(6):630–635. PubMed PMID: 11679789.
   Google Scholar
• Shaw GM, Quach T, Nelson V, et al. Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr. 2003 Nov;78(5):972–978. PubMed PMID: 14594784.
   Google Scholar
• Yazdy MM, Liu S, Mitchell AA, et al. Maternal dietary glycemic intake and the risk of neural tube defects. Am J Epidemiol. 2010 Feb 15;171(4):407–414. PubMed PMID: 20042435; PubMed Central PMCID: PMCPMC2842193.
   Google Scholar
• Ray JG, Thompson MD, Vermeulen MJ, et al. Metabolic syndrome features and risk of neural tube defects. BMC Pregnancy Childbirth. 2007 Sep 19;7:21. PubMed PMID: 17880716; PubMed Central PMCID: PMCPMC2039731.
   Google Scholar
• Greene DA. Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve. Drugs. 1986;32(Suppl 2):6–14. PubMed PMID: 3024950.
   Google Scholar
• Cockroft DL, Brook FA, Copp AJ. Inositol deficiency increases the susceptibility to neural tube defects of genetically predisposed (curly tail) mouse embryos in vitro. Teratology. 1992 Feb;45(2):223–232. PubMed PMID: 1615432.
   Google Scholar
• Baker L, Piddington R, Goldman A, et al. Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos. Diabetologia. 1990 Oct;33(10):593–596. PubMed PMID: 2257996.
   Google Scholar
• Khandelwal M, Reece EA, Wu YK, et al. Dietary myo-inositol therapy in hyperglycemia-induced embryopathy. Teratology. 1998 Feb;57(2):79–84. PubMed PMID: 9562680.
   Google Scholar
• Greene ND, Copp AJ. Inositol prevents folate-resistant neural tube defects in the mouse. Nat Med. 1997 Jan;3(1):60–66. PubMed PMID: 8986742.
   Google Scholar
• Gustavsson P, Copp AJ, Greene ND. Grainyhead genes and mammalian neural tube closure. Birth Defects Res A Clin Mol Teratol. 2008 Oct;82(10):728–735. PubMed PMID: 18683893.
   Google Scholar
• De Castro SC, Malhas A, Leung KY, et al. Lamin b1 polymorphism influences morphology of the nuclear envelope, cell cycle progression, and risk of neural tube defects in mice. PLoS Genet. 2012;8(11):e1003059. PubMed PMID: 23166514; PubMed Central PMCID: PMCPMC3499363.
   Google Scholar
• Cogram P, Tesh S, Tesh J, et al. D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects. Hum Reprod. 2002 Sep;17(9):2451–2458. PubMed PMID: 12202440.
   Google Scholar
• Cogram P, Hynes A, Dunlevy LP, et al. Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol. Hum Mol Genet. 2004 Jan 1;13(1):7–14. PubMed PMID: 14613966.
   Google Scholar
• Ting SB, Wilanowski T, Auden A, et al. Inositol- and folate-resistant neural tube defects in mice lacking the epithelial-specific factor Grhl-3. Nat Med. 2003 Dec;9(12):1513–1519. PubMed PMID: 14608380.
   Google Scholar
• Burren KA, Scott JM, Copp AJ, et al. The genetic background of the curly tail strain confers susceptibility to folate-deficiency-induced exencephaly. Birth Defects Res A Clin Mol Teratol. 2010 Feb;88(2):76–83. PubMed PMID: 19824061; PubMed Central PMCID: PMCPMC3071937.
   Google Scholar
• Groenen PM, Peer PG, Wevers RA, et al. Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol. 2003 Dec;189(6):1713–1719. PubMed PMID: 14710103.
   Google Scholar
• Wilson MP, Hugge C, Bielinska M, et al. Neural tube defects in mice with reduced levels of inositol 1,3,4-trisphosphate 5/6-kinase. Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9831–9835. PubMed PMID: 19482943; PubMed Central PMCID: PMCPMC2701051.
   Google Scholar
• Guan Z, Wang J, Guo J, et al. The maternal ITPK1 gene polymorphism is associated with neural tube defects in a high-risk Chinese population. PLoS One. 2014;9(1):e86145. PubMed PMID: 24465924; PubMed Central PMCID: PMCPMC3896452. eng.
   Google Scholar
• Cavalli P, Ronda E. Myoinositol: the bridge (PONTI) to reach a healthy pregnancy. Int J Endocrinol. 2017;2017:5846286. PubMed PMID: 28243254; PubMed Central PMCID: PMCPMC5274721.
   Google Scholar
• Greene ND, Leung KY, Gay V, et al. Inositol for the prevention of neural tube defects: a pilot randomised controlled trial. Br J Nutr. 2016 Mar 28;115(6):974–983. PubMed PMID: 26847388; PubMed Central PMCID: PMCPMC4825100.
   Google Scholar
• Firth HV, Hurst JA. Clinical genetics and genomics (Oxford Desk Ref). 2nd ed. Oxford: Oxford University Press; 2017.
   Google Scholar
• Glasziou P, Chalmers I, Rawlins M, et al. When are randomised trials unnecessary? Picking signal from noise. BMJ. 2007 Feb 17;334(7589):349–351. PubMed PMID: 17303884; PubMed Central PMCID: PMCPMC1800999.
   Google Scholar
• Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987 Jul 16;317(3):141–145. PubMed PMID: 3600702.
   Google Scholar
• Agha-Jaffar R, Oliver N, Johnston D, et al. Gestational diabetes mellitus: does an effective prevention strategy exist? Nat Rev Endocrinol. 2016 Sep;12(9):533–546. PubMed PMID: 27339886.
   Google Scholar